Department of Hepatobiliary and Pancreatic Surgery, The Third Affiliated Hospital of Soochow University, Jiangsu, China.
Department of Neurosurgery, Xinyi People's Hospital, Jiangsu, China.
Comput Math Methods Med. 2021 Dec 28;2021:4439505. doi: 10.1155/2021/4439505. eCollection 2021.
Hepatoma is a leading cause of death worldwide, with high metastasis and recurrence rates. The aberrant expression of miRNA-130a-5p is involved in the development and progression of various cancers. However, there are no studies investigating the role of miRNA-130a-5p in hepatoma. The present study is aimed at clarifying the functional role of miRNA-130a-5p in hepatoma progression.
The expression levels of miRNA-130a-5p in hepatoma tissues and cell lines were detected by qRT-PCR assays. Bioinformatic analysis, gain-/loss-of-function experiments, and luciferase activity assays were conducted to verify whether miRNA-130a-5p is targeted by protein tyrosine phosphatase 4A2 (PTP4A2). The functions of miRNA-130a-5p and PTP4A2 in hepatoma were determined by cell proliferation assays.
The expression of miRNA-130a-5p was downregulated in hepatoma tissues and was related to poor prognosis. However, the expression level of PTP4A2 was contradictory to that of miRNA-130a-5p, and PTP4A2 upregulation could aggravate hepatoma progression. The ectopic overexpression of PTP4A2 promoted hepatoma cell proliferation in vitro, which could be reversed by miRNA-130a-5p.
Our study implies that miRNA-130a-5p, which is downregulated in hepatoma tissues, can suppress hepatoma cell proliferation via targeting PTP4A2.
肝癌是全球主要的死亡原因之一,其转移和复发率较高。miRNA-130a-5p 的异常表达与多种癌症的发生和发展有关。然而,目前尚无研究探讨 miRNA-130a-5p 在肝癌中的作用。本研究旨在阐明 miRNA-130a-5p 在肝癌进展中的功能作用。
通过 qRT-PCR 检测肝癌组织和细胞系中 miRNA-130a-5p 的表达水平。通过生物信息学分析、增益/缺失功能实验和荧光素酶活性测定验证 miRNA-130a-5p 是否为蛋白酪氨酸磷酸酶 4A2(PTP4A2)的靶基因。通过细胞增殖实验确定 miRNA-130a-5p 和 PTP4A2 在肝癌中的功能。
miRNA-130a-5p 在肝癌组织中表达下调,与预后不良相关。然而,PTP4A2 的表达水平与 miRNA-130a-5p 相反,PTP4A2 的上调可加重肝癌的进展。PTP4A2 的异位过表达可促进肝癌细胞在体外的增殖,而 miRNA-130a-5p 可逆转这种作用。
我们的研究表明,在肝癌组织中下调的 miRNA-130a-5p 可通过靶向 PTP4A2 抑制肝癌细胞的增殖。